Some studies have reported that HuR overexpression can also inhibit the translation of selective inflammatory mRNAs, suggesting that HuR may act as a negative regulator of pathological inflammation (147), thereby mitigating intestinal inflammation and CRC progression (132, 146). Here, ELAVL1 is linked to colorectal carcinoma.